YAP1 and metabolic dysfunction-associated steatotic liver disease: In addition, given the incomplete understanding of the mechanism by which YAP/TAZ are redistributed and activated in different hepatic cells during MASLD, it is inadvisable to rely on a single general mechanism for YAP/TAZ regulation.